Liv B. Gansmo

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy.

The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy.

Journal: BMC cancer
Published: November 22, 2024

APOBEC3A/B deletion polymorphism and endometrial cancer risk.

APOBEC3A/B deletion polymorphism and endometrial cancer risk.

Journal: Cancer medicine
Published: July 15, 2022

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.

Journal: Scientific reports
Published: June 02, 2021

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: March 01, 2021

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.

Journal: Gene
Published: February 11, 2021

APOBEC3A/B deletion polymorphism and cancer risk.

APOBEC3A/B deletion polymorphism and cancer risk.

Journal: Carcinogenesis
Published: November 16, 2017

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.

Journal: Translational oncology
Published: June 19, 2017

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.

Journal: BMC cell biology
Published: October 30, 2016

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.

Journal: BMC cancer
Published: October 12, 2016

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.

Journal: Scientific reports
Published: May 25, 2016

Prevalence of the CHEK2 R95* germline mutation.

Prevalence of the CHEK2 R95* germline mutation.

Journal: Hereditary cancer in clinical practice
Published: March 13, 2016

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.

Journal: Oncotarget
Published: February 16, 2016
Showing 1-12 of 17

Last Updated: 09/26/2026